Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RMTI

RMTI - Rockwell Medical Inc Stock Price, Fair Value and News

$1.13-0.02 (-1.74%)
Market Closed

41/100

RMTI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

41/100

RMTI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.05

Target 3M

$1.12

Target 6M

$1.1

RMTI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RMTI Price Action

Last 7 days

-8.1%

Last 30 days

39.5%

Last 90 days

4.6%

Trailing 12 Months

-46.7%

RMTI RSI Chart

RMTI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RMTI Valuation

Market Cap

44.5M

Price/Earnings (Trailing)

-8.07

Price/Sales (Trailing)

0.59

EV/EBITDA

-1.33

Price/Free Cashflow

-21.34

RMTI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.05

Target 3M

$1.12

Target 6M

$1.1

RMTI Fundamentals

RMTI Revenue

Revenue (TTM)

75.6M

Rev. Growth (Yr)

-43.75%

Rev. Growth (Qtr)

-0.9%

RMTI Earnings

Earnings (TTM)

-5.5M

Earnings Growth (Yr)

-205.35%

Earnings Growth (Qtr)

-17.49%

RMTI Profitability

EBT Margin

-36.66%

Return on Equity

-14.9%

Return on Assets

-9.6%

Free Cashflow Yield

-4.69%

RMTI Investor Care

Shares Dilution (1Y)

21.93%

Diluted EPS (TTM)

-0.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202597.7M88.0M75.6M0
202486.6M94.4M98.9M101.5M
202376.4M75.8M80.8M83.6M
202262.6M66.1M68.8M72.8M
202161.8M61.1M61.8M61.9M
202061.6M62.7M62.5M62.2M
201964.0M63.9M62.7M61.3M
201857.7M59.3M61.4M63.4M
201754.2M54.0M55.9M57.3M
201655.1M55.6M54.0M53.3M
201555.1M55.0M55.7M55.4M
201453.0M53.1M53.7M54.2M
201350.2M51.0M51.4M52.4M
201247.7M48.0M48.7M49.8M
201157.9M54.2M51.4M49.0M
201000059.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Rockwell Medical Inc

RMTI
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including cleaning agents, 6% bleach for disinfection, citric acid descale, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
 CEO
 WEBSITErockwellmed.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES253

Rockwell Medical Inc Frequently Asked Questions

RMTI is the stock ticker symbol of Rockwell Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Rockwell Medical Inc is 44.53 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RMTI's fair value in chart for subscribers.

The fair value guage provides a quick view whether RMTI is over valued or under valued. Whether Rockwell Medical Inc is cheap or expensive depends on the assumptions which impact Rockwell Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RMTI.

As of Wed Jan 28 2026, RMTI's PE ratio (Price to Earnings) is -8.07 and Price to Sales (PS) ratio is 0.59. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RMTI PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Rockwell Medical Inc has provided -0.337 (multiply by 100 for percentage) rate of return.